CHERYL FEKEN: Open Payments
NPI 1679008809 · BROKEN ARROW, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$406 in 18 payments from 12 companies in 2025. Trend: 2023 $1,096 · 2024 $501 · 2025 $406
Food & beverage: $406
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $114 |
| AstraZeneca Pharmaceuticals LP | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 2 | $37 |
| Lilly USA, LLC | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Amgen Inc. | 2 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $22 |
| Viatris Specialty LLC | 1 | $17 |
| Boston Scientific Corporation | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: JARDIANCE, REXULTI, MOUNJARO, Cologuard Collection Kit, XIFAXAN, YUPELRI, Bulkamid, TRELEGY ELLIPTA.
Industry payments across OK — which companies pay providers there.
